Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy

Journal:

Cell Host & Microbe

Published:

2025-06-11

DOI:

10.1016/j.chom.2025.04.022

Affiliations:

5

Authors:

19

Go to article

Institutions	Authors	Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China	11.000000 11.000000	0.58
Nanjing University of Chinese Medicine (NJUCM), China	5.000000	0.26
The Affiliated Huaian No.1 People's Hospital, NJMU, China	2.000000	0.11
Shandong Provincial Hospital, China	1.000000	0.05

Interested in Clinical Sciences?